Related Experiment Video
Updated: Oct 16, 2025

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
Published on: August 21, 2019
Therapeutic Targeting of Cancer Stem Cells in Lung, Head and Neck, and Bladder Cancers
Sarah E Mudra1, Pritam Sadhukhan2, M Talha Ugurlu2
1School of Medicine, University of Louisville, Louisville, KY 40202, USA.
Abstract:
Resistance to cancer therapy remains a significant obstacle in treating patients with various solid malignancies. Exposure to current chemotherapeutics and targeted agents invariably leads to therapy resistance, heralding the need for novel agents. Cancer stem cells (CSCs)-a subpopulation of tumor cells with capacities for self-renewal and multi-lineage differentiation-represent a pool of therapeutically resistant cells. CSCs often share physical and molecular characteristics with the stem cell population of the human body. It remains challenging to selectively target CSCs in therapeutically resistant tumors. The generation of CSCs and induction of therapeutic resistance can be attributed to several deregulated critical growth regulatory signaling pathways such as WNT/β-catenin, Notch, Hippo, and Hedgehog. Beyond growth regulatory pathways, CSCs also change the tumor microenvironment and resist endogenous immune attack. Thus, CSCs can interfere with each stage of carcinogenesis from malignant transformation to the onset of metastasis to tumor recurrence. A thorough review of novel targeted agents to act against CSCs is fundamental for advancing cancer treatment in the setting of both intrinsic and acquired resistance.
Insights
Cancer stem cells (CSCs) drive therapy resistance in solid tumors. Novel targeted agents are crucial to overcome this resistance and improve cancer treatment outcomes.
Area of Science:
- Oncology
- Cancer Biology
- Stem Cell Research
Background:
- Therapy resistance is a major challenge in treating solid malignancies.
- Cancer stem cells (CSCs) are a resistant subpopulation crucial for tumor recurrence and metastasis.
- Targeting CSCs is essential for overcoming therapeutic resistance.
Purpose of the Study:
- To review novel targeted agents for combating cancer stem cells (CSCs).
- To highlight the role of CSCs in intrinsic and acquired therapy resistance.
- To discuss strategies for selectively targeting CSCs in resistant tumors.
Main Methods:
- Literature review of novel targeted agents against CSCs.
- Analysis of signaling pathways (WNT/β-catenin, Notch, Hippo, Hedgehog) involved in CSC generation and resistance.
- Examination of CSC interaction with the tumor microenvironment and immune system.
Main Results:
- CSCs possess self-renewal and differentiation capacities, contributing to therapeutic resistance.
- Deregulated signaling pathways are implicated in CSC generation and resistance.
- CSCs influence carcinogenesis, metastasis, and tumor recurrence.
Conclusions:
- Novel targeted agents are fundamental for advancing cancer treatment against resistant tumors.
- Understanding CSC biology and resistance mechanisms is key to developing effective therapies.
- Selective targeting of CSCs offers a promising strategy to overcome intrinsic and acquired resistance.
More Related Videos
11:28Isolation and Characterization of a Head and Neck Squamous Cell Carcinoma Subpopulation Having Stem Cell Characteristics
Published on: May 11, 2016
05:08Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
Published on: February 17, 2019
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy